ZA793295B - Phenethanolamines,formulations and potentiation of oncolytic drugs - Google Patents

Phenethanolamines,formulations and potentiation of oncolytic drugs

Info

Publication number
ZA793295B
ZA793295B ZA793295A ZA793295A ZA793295B ZA 793295 B ZA793295 B ZA 793295B ZA 793295 A ZA793295 A ZA 793295A ZA 793295 A ZA793295 A ZA 793295A ZA 793295 B ZA793295 B ZA 793295B
Authority
ZA
South Africa
Prior art keywords
phenethanolamines
potentiation
formulations
oncolytic drugs
oncolytic
Prior art date
Application number
ZA793295A
Other languages
English (en)
Inventor
J Mills
R Toomey
K Schmiegel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA793295B publication Critical patent/ZA793295B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA793295A 1978-07-03 1979-07-03 Phenethanolamines,formulations and potentiation of oncolytic drugs ZA793295B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
ZA793295B true ZA793295B (en) 1981-02-25

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA793295A ZA793295B (en) 1978-07-03 1979-07-03 Phenethanolamines,formulations and potentiation of oncolytic drugs

Country Status (33)

Country Link
EP (2) EP0047536B1 (nl)
JP (1) JPS559100A (nl)
AR (2) AR222658A1 (nl)
AT (1) AT370408B (nl)
AU (1) AU521744B2 (nl)
BE (1) BE877392A (nl)
BG (3) BG40482A3 (nl)
CA (1) CA1120058A (nl)
CH (1) CH641759A5 (nl)
CS (2) CS208660B2 (nl)
DD (1) DD144763A5 (nl)
DK (1) DK268579A (nl)
EG (1) EG14400A (nl)
ES (2) ES482153A1 (nl)
FI (1) FI67686C (nl)
FR (1) FR2430409A1 (nl)
GB (1) GB2028800B (nl)
GR (1) GR72546B (nl)
HK (1) HK44087A (nl)
HU (1) HU179170B (nl)
IE (1) IE48436B1 (nl)
IL (1) IL57670A (nl)
LU (1) LU81456A1 (nl)
MX (1) MX6160E (nl)
MY (1) MY8500596A (nl)
NZ (1) NZ190859A (nl)
PH (1) PH15650A (nl)
PL (2) PL123990B1 (nl)
PT (1) PT69840A (nl)
RO (2) RO83053B (nl)
SU (2) SU965351A3 (nl)
YU (1) YU154879A (nl)
ZA (1) ZA793295B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (en) * 1981-06-20 1983-01-05 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (en) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them
PL144053B1 (en) * 1983-01-31 1988-04-30 Lilly Co Eli Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β-拟肾上腺素兴奋剂型饲料添加剂的合成方法
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (nl) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
AR222658A1 (es) 1981-06-15
SU931102A3 (ru) 1982-05-23
IE791231L (en) 1980-01-03
EP0007206A1 (en) 1980-01-23
FR2430409B1 (nl) 1981-05-29
MY8500596A (en) 1985-12-31
ATA463979A (de) 1982-08-15
NZ190859A (en) 1984-09-28
CS208660B2 (en) 1981-09-15
LU81456A1 (fr) 1979-10-30
SU965351A3 (ru) 1982-10-07
ES8101537A1 (es) 1980-12-16
GR72546B (nl) 1983-11-17
IE48436B1 (en) 1985-01-23
FI67686C (fi) 1985-05-10
AR222727A1 (es) 1981-06-15
HU179170B (en) 1982-08-28
RO83053A (ro) 1984-02-21
EG14400A (en) 1983-12-31
GB2028800A (en) 1980-03-12
PL123990B1 (en) 1982-12-31
BG40480A3 (en) 1986-12-15
BG40482A3 (en) 1986-12-15
EP0047536A2 (en) 1982-03-17
FI792080A (fi) 1980-01-04
PH15650A (en) 1983-03-11
DK268579A (da) 1980-01-04
BG40481A3 (en) 1986-12-15
JPS636058B2 (nl) 1988-02-08
RO77731A (ro) 1981-11-24
FR2430409A1 (fr) 1980-02-01
BE877392A (fr) 1980-01-02
GB2028800B (en) 1982-11-03
ES482153A1 (es) 1980-08-16
EP0007206B1 (en) 1983-02-23
EP0047536A3 (en) 1982-03-24
AU4848879A (en) 1980-01-10
AU521744B2 (en) 1982-04-29
YU154879A (en) 1983-04-30
CA1120058A (en) 1982-03-16
EP0047536B1 (en) 1984-06-27
RO83053B (ro) 1984-02-28
DD144763A5 (de) 1980-11-05
MX6160E (es) 1984-11-29
FI67686B (fi) 1985-01-31
AT370408B (de) 1983-03-25
PL119783B1 (en) 1982-01-30
HK44087A (en) 1987-06-12
PL222867A1 (nl) 1981-01-02
PL216810A1 (nl) 1980-07-28
ES487847A0 (es) 1980-12-16
IL57670A (en) 1982-11-30
PT69840A (en) 1979-07-01
CS208661B2 (en) 1981-09-15
JPS559100A (en) 1980-01-22
CH641759A5 (fr) 1984-03-15
IL57670A0 (en) 1979-10-31

Similar Documents

Publication Publication Date Title
DE2964091D1 (en) Phenethanolamines, their formulations, use and preparation
DE2963797D1 (en) Amino-dibenzopyrans, their preparation, formulations containing them and their use as pharmaceuticals
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
ZA793295B (en) Phenethanolamines,formulations and potentiation of oncolytic drugs
DE3162404D1 (en) Pharmaceutical amides, and preparation, formulations and use thereof
DE2963061D1 (en) Hydantoin compounds, their preparation and pharmaceutical formulations containing them
GB2038812B (en) 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof
DE2961575D1 (en) 1-substituted-thiomethyltriazolobenzodiazepines, preparation thereof, their use, and a pharmaceutical composition
IL57599A0 (en) Indolealkylamines,pharmaceutical formulations containing these and processes for their preparation
DE2965443D1 (en) Novel anti-hypertensive mercaptoacylamino acid derivatives, their preparation and use
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
MY8500281A (en) Pharmaceutical and food formulations
ZA79395B (en) Pharmaceutical formulations
DE2966364D1 (en) Phenyl-alkanoic acid derivatives, the preparation thereof and pharmaceutical compositions containing them
ZA793131B (en) Indolealkylamines,pharmaceutical formulations containing these,and processes for their preparation
DE2960506D1 (en) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
IL56816A0 (en) N-phenylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL57862A0 (en) 1-benzoyl-3-pyridinyl ureas,their use,preparation and formulations
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
IL56913A (en) Sprio-steroid-oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL57504A0 (en) Prostagandin analogues,their preparation and pharmaceutical compositions containing
IL56728A (en) Androstadienes,their preparation and pharmaceutical compositions containing them
DE2963868D1 (en) Carbostyrile derivatives, their preparation and pharmaceutical compositions containing them